Exclusive investigation reveals the soaring financial and human cost of new obesity drugs. As millions rely on Wegovy and Ozempic, the NHS faces a multi-billion pound dilemma when patients stop treatment and weight returns.
Exclusive: The NHS faces a financial timebomb as new analysis reveals prescribing weight-loss drugs like Wegovy could cost twice the entire current GP prescribing budget, sparking a national rationing debate.
New generation weight-loss medications are doing more than suppress appetite; they're fundamentally altering our psychological and emotional connections to eating, raising profound questions for individuals and society.
Model and TV personality Chrissy Teigen opens up in a raw and emotional interview about her Ozempic-fuelled weight loss journey and the tragic miscarriage she believes it caused, sparking a crucial conversation on medication safety.
Model and TV personality Chrissy Teigen breaks her silence on using diabetes drug Ozempic for weight loss, sparking debate on celebrity wellness trends and pharmaceutical ethics.
A major UK trial reveals the new semaglutide pill, a potential game-changer in obesity treatment, leads to significant weight loss, offering a powerful alternative to injections.
A landmark UK study reveals the new weight loss injection Tirzepatide is significantly more effective than existing treatments, helping patients lose over 20% of their body weight and offering new hope in the fight against obesity.
An Alabama death row inmate uttered the haunting phrase 'Let's ride' moments before a 'botched' lethal injection that took over an hour to complete, sparking renewed outrage over capital punishment in the US.
The US state of Florida has carried out the execution of David Pittman for the 2003 murder of his 23-year-old neighbour. The controversial case saw his final meal request denied as he became the ninth inmate put to death this year.
Groundbreaking research reveals that blockbuster weight-loss jabs do more than suppress appetite—they may fundamentally change the brain's response to food, offering new hope for tackling compulsive eating disorders.
A new oral weight loss drug, Orforglipron, shows staggering results in a major clinical trial, offering a powerful and convenient alternative to injectable treatments for obesity.
Steven Bixby has been executed by lethal injection in South Carolina for the 2003 murders of a sheriff's deputy and a state official, marking the state's first execution since 2011.
New research reveals that GLP-1 weight-loss injections not only aid in shedding pounds but also significantly quiet intrusive thoughts about food, offering a dual benefit for patients.
Groundbreaking NHS research reveals obesity injections like Wegovy are dramatically more effective than lifestyle changes alone for teenagers, offering new hope in the childhood obesity crisis.
Groundbreaking UK research suggests GLP-1 weight-loss injections, including Wegovy, may dramatically reduce the risk of obesity-related cancers, offering new hope in preventative oncology.
The NHS is rolling out a powerful new 4mg weekly injection of semaglutide, a 'game-changer' in weight loss treatment, as part of a major strategy to tackle the nation's obesity epidemic.
The NHS receives a powerful new weapon in the fight against obesity as medical regulators approve a higher 2.4mg dose of Wegovy, proven to help patients shed significantly more weight.
A British mother who lost eight stone using 'fat jabs' has sparked a fierce debate by arguing the NHS should not fund them for weight loss, calling it a personal lifestyle choice rather than an essential right.
Exclusive: The UK government is quietly investigating controversial solar radiation management technologies, including stratospheric aerosol injection, as a potential emergency response to climate change, the Independent can reveal.
UK health officials issue urgent safety alert for popular slimming injections like Ozempic and Wegovy. Patients must disclose use before operations to prevent dangerous complications.
Groundbreaking research from Tufts University reveals that drugs like Ozempic and Wegovy are dramatically more effective for weight loss than traditional diet and exercise alone, potentially transforming the NHS's approach to the obesity epidemic.
A new oral weight loss medication, Orforglipron, shows transformative potential in UK clinical trials, matching the efficacy of injectable treatments like Mounjaro and offering new hope for tackling obesity.
Exclusive: The NHS is now prescribing powerful diabetes medications Ozempic and Mounjaro for weight loss, sparking a massive surge in demand and a fierce debate over ethics and supply.
A UK mother's revelation that she uses her disability benefits to pay for weight-loss jabs like Wegovy has ignited a fierce national debate on welfare spending, medical ethics, and obesity treatment.
The World Health Organisation makes a landmark decision, adding weight-loss injections like Wegovy to its Essential Medicines List, signalling a new front in the global fight against obesity.
The NHS is dramatically expanding the availability of prescription weight-loss injections, hailed as a 'game-changer' in treating obesity. This major rollout could benefit hundreds of thousands more patients across England.
Health experts sound the alarm on a worrying new trend where individuals are microdosing powerful diabetes and weight-loss medications like Ozempic to shed pounds, despite severe health risks and a complete lack of evidence for its safety or efficacy.
UK researchers are exploring a revolutionary 'microdosing' strategy for powerful weight-loss medications like Wegovy, potentially slashing costs and side effects while boosting accessibility for NHS patients.
Exclusive investigation reveals the staggering postcode lottery and soaring costs of life-changing obesity drugs like Mounjaro and Wegovy, as the NHS struggles to cope with unprecedented demand.
EXCLUSIVE: Tracey Cox exposes the hidden intimate costs of semaglutide injections. Discover why your marriage and sex life could be the ultimate price for rapid weight loss.